Minerva

NERV NASDAQ
4.380
-0.020
-0.45%
已收盘, 16:25 06/17 EDT
开盘
4.420
昨收
4.400
最高
4.550
最低
4.360
成交量
21.16万
成交均量(3M)
14.94万
52周最高
12.95
52周最低
4.360
换手率
0.54%
市值
1.71亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Minerva NERV股票价格,Minerva股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system (CNS) diseases. The Company's product portfolio and indications include MIN-101 for the treatment of schizophrenia; MIN-202, for the treatment of insomnia disorder and major depressive disorder (MDD); MIN-117, for the treatment of MDD, and MIN-301 for the treatment of Parkinson's disease. MIN-101 is a compound that blocks serotonin receptors and sigma receptors, two receptors in the brain that are involved in the regulation of mood, cognition, sleep and anxiety. MIN-117 is meant to block a specific subtype of serotonin receptor called 5-hydroxytryptamine type 1A (5-HT1A). MIN-202 is a selective orexin 2 receptor antagonist. MIN-301 is a soluble recombinant form of the Neuregulin-1b1 (NRG-1b1) protein, for the treatment of Parkinson's disease.
展开 >

最近浏览

名称
价格
涨跌幅